Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$23.37 - $32.13 $612,831 - $842,544
-26,223 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$18.78 - $25.15 $492,467 - $659,508
26,223 New
26,223 $643,000
Q1 2020

May 11, 2020

SELL
$13.06 - $21.24 $413,087 - $671,821
-31,630 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$17.29 - $21.74 $546,882 - $687,636
31,630 New
31,630 $645,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.45B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.